ArticleOncotarget2017
Probiotics in 14-day triple therapy for Asian pediatric patients with
Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 32 citations in OpenAlex.
- Potassium-competitive acid blockers forFrontiers in cellular and infection microbiology · 2026Review
- Update on the Management of Helicobacter pylori Infection in Children and Adolescents.Current gastroenterology reports · 2025Review
- Probiotic strainGut microbes reports · 2025Article
- The Impact of Bioactive Molecules from Probiotics on Child Health: A Comprehensive Review.Nutrients · 2024Review
- Review
- Therapeutic eradication choices inTherapeutic advances in gastroenterology · 2023Review
- Comparison of multiple treatment regimens in children withFrontiers in cellular and infection microbiology · 2023Article
- Host Cell Antimicrobial Responses againstInternational journal of molecular sciences · 2022Review
- Are pro- and/or synbiotics beneficial in Helicobacter pylori eradication therapy in children? A narrative review.European journal of pediatrics · 2022Review
- The Challenges of Eradicating PediatricChildren (Basel, Switzerland) · 2022Review
- A scoping review of network meta-analyses assessing the efficacy and safety of complementary and alternative medicine interventions.Systematic reviews · 2020Article
- Recommendations for the adjuvant use of the poly-antibiotic-resistant probioticTropical diseases, travel medicine and vaccines · 2020Review
- Current and Future Treatment of Helicobacter pylori Infections.Advances in experimental medicine and biology · 2019Review
- What Roles Do Probiotics Play in the Eradication ofGastroenterology research and practice · 2018Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although 14-day triple therapy has been widely administrated for eradicating MATERIALS AND
methodsRandomized controlled trials (RCTs) were retrieved comprehensively in electronic databases (such as PubMed, Cochrane library, Embase, CNKI, Wan fang database, VIP database and CBM) until April 2017. Additional references were obtained from reviewed articles. NMA was performed using a random-effects model under a frequentist framework.
resultsSeventeen RCTs were included. NMA indicated that
conclusions
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.